Beam Therapeutics Inc (BEAM) — Free Cash Flow Generation Index
Beam Therapeutics Inc (BEAM) has a Free Cash Flow Generation Index of 0.97x as of December 2023. Free cash flow of $131.48 Million represents 1% of operating cash flow ($135.07 Million). Explore Beam Therapeutics Inc (BEAM) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beam Therapeutics Inc Free Cash Flow Generation Index (2022–2022)
Historical FCF Generation Index trend for Beam Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see BEAM operating cash flow.
Annual Free Cash Flow Generation for Beam Therapeutics Inc (2022–2022)
Year-by-year Free Cash Flow Generation Index for Beam Therapeutics Inc. Check BEAM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.17x | $-26.42 Million | $22.53 Million | $48.95 Million | — |